CompoAtlas

新寶婦康蔓越莓膠囊食品

新寶婦康蔓越莓膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
CRANBERRY POWDERCRANBERRY POWDERNot identified
BORAGE SEED OILBORAGE SEED OILNot identified
POMEGRANATE (PUNICA GRANATUM L.)POMEGRANATE (PUNICA GRANATUM L.)Not identified
ROYAL JELLYROYAL JELLYGelée royale
LACTOBACILLUS ACIDOPHILUSLACTOBACILLUS ACIDOPHILUSNot identified
LACTOBACILLUS BULGARICUSLACTOBACILLUS BULGARICUSNot identified
STREPTOCOCCUS THERMOPHILUSSTREPTOCOCCUS THERMOPHILUSNot identified
SOYBEAN OILSOYBEAN OILNot identified
SOY LECITHINSOY LECITHINNot identified
BEESWAXBEESWAXNot identified
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
PURIFIED WATERPURIFIED WATERNot identified
BEET RED COLORBEET RED COLORNot identified
TITANIUM DIOXIDETITANIUM DIOXIDENot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Product record

Registration number
1076608308
Chinese name
新寶婦康蔓越莓膠囊食品
English name
NEW BAOFUKANG CRANBERRY CAPSULES
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
德效國際有限公司
Registration date
2018-11-08
Published validity end
2028-11-08

Original register data

View published fields and their variants
Product name
新寶婦康蔓越莓膠囊食品
Active ingredients
CRANBERRY POWDER;;BORAGE SEED OIL;;POMEGRANATE (PUNICA GRANATUM L.);;ROYAL JELLY;;LACTOBACILLUS ACIDOPHILUS;;LACTOBACILLUS BULGARICUS;;STREPTOCOCCUS THERMOPHILUS;;SOYBEAN OIL;;SOY LECITHIN;;BEESWAX;;GELATIN;;GLYCEROL;;PURIFIED WATER;;BEET RED COLOR;;TITANIUM DIOXIDE;;
Valid until
1171108
Registration number
1076608308
Licence holder
德效國際有限公司
Registration date
1071108
Published reference
DHC0A766083089
Published English name
NEW BAOFUKANG CRANBERRY CAPSULES

Official source

View the official register, number 1076608308

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • ROYAL JELLY
    Read the warning, when it applies and the studies cited

    ROYAL JELLY

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Contraindications

    Do not use if you have a history of asthma or allergies (TGA 2001; Leung et al. 1997; Harwood et al. 1996; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995; Bullock 1994).

    Sources cited by Health Canada (8)
    • Bullock RJ. Fatal royal-jelly induced asthma. Medical Journal of Australia 1994;160:44. PubMed Case report
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • TGA 2001: Australian Therapeutic Goods Administration. CMEC 28: Complementary Medicines Evaluation Committee, Extracted Ratified Minutes twenty-eight Meeting, 27-28 July 2001. Australian Government Department of Health and Aging, Sydney, Australia; 2001. [Accessed 2025 February 5]. Available from: https://www.tga.gov.au/sites/default/files/cmec-minutes-28.pdf
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed

    Known adverse reactions

    Stop use if hypersensitivity/allergy occurs (Leung et al. 1997; Laporte et al. 1996; Thien et al. 1996; Leung et al. 1995; Peacock et al. 1995).

    Sources cited by Health Canada (6)
    • Laporte JR, Ibaanez L, Vendrell L, Ballarin E. Bronchospasm induced by royal jelly. Allergy 1996;51:440. PubMed
    • Leung R, Ho A, Chan J, Choy D, Lai CK. Royal jelly consumption and hypersensitivity in the community. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1997;27(3):333-336. PubMed
    • Leung R, Thien FC, Baldo B. Royal Jelly-induced asthma and anaphylaxis: clinical characteristics and immunologic correlations. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1995;96:1004-1007. PubMed Case report
    • Peacock S, Muray V, Turton C. Respiratory distress and royal jelly. British Medical Journal 1995;311:1472. PubMed Case report
    • Thien FC, Leung R, Baldo BA, Weiner JA, Plomley R, Czarny D. Asthma and anaphylaxis induced by royal jelly. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology 1996;26(2):216-222. PubMed
    • Harwood M, Harding S, Beasley R, Frankish PD. Asthma following royal jelly. The New Zealand Medical Journal 1996;109:325. PubMed Case report

    Health Canada monograph dated 24 April 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “新寶婦康蔓越莓膠囊食品”, https://compoatlas.com/en/supplements/taiwan/1076608308-new-baofukang-cranberry-capsules, updated 27 October 2026.

Enter to analyse, Shift+Enter for a new line